Peter Ho is joining Boston Pharmaceuticals as chief medical officer. He comes to the Cambridge, MA-based drug developer from Epizyme (NASDAQ: [[ticker:EPZM]]), where he also served as chief medical officer. His experience includes posts at Johnson & Johnson (NYSE: [[ticker:JNJ]]), the National Cancer Institute, Novartis (NYSE: [[ticker:NVS]]), and DuPont Pharmaceuticals.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
